American Society of Clinical Oncology

SHERPA: White

People

  1. Schwartz
    Schwartz
  2. Scher
    Scher
  3. Bajorin
    Bajorin
  4. Heller
    Heller
  5. Kris
    Kris
  6. Motzer
    Motzer
  7. Slovin
    Slovin
  8. Berkowitz
    Berkowitz
  9. Bosl
    Bosl
  10. Carrasquillo
    Carrasquillo

Groups

  1. Body Imaging Service (11)
  2. Department of Medicine (11)
  3. Nursing (11)
  4. Radiology, Department of (11)
  5. Solid Tumor Oncology Division (10)
  6. Genitourinary Oncology Service (7)
  7. Sloan Kettering Institute Faculty (4)
  8. GSK Faculty (3)
  9. Hematologic Malignancies, Division of (3)
  10. Molecular Pharmacology and Chemistry Program Faculty (3)
Search Within
  1. "Nursing"
  2. "Lawrence Schwartz"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (3)
Groups
  1. Body Imaging Service (11)
  2. Department of Medicine (11)
  3. Nursing (11)
  4. Radiology, Department of (11)
  5. Solid Tumor Oncology Division (10)
  6. Genitourinary Oncology Service (7)

More Groups

People
  1. Lawrence Schwartz (11)
  2. Howard Scher (6)
  3. William Kelly (5)
  4. Tracy Smart-Curley (4)
  5. Binsheng Zhao (2)
  6. Dean Bajorin (2)

More People

Years
  1. 2013 (1)
  2. 2009 (1)
  3. 2007 (1)
  4. 2006 (3)
  5. 2005 (1)
  6. 2001 (1)

More Years

Publications
  1. Journal of Clinical Oncology (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial
    Journal Article

    Pietanza, M. C.; Basch, E. M.; Lash, A.; Schwartz, L. H.; Ginsberg, M. S.; Zhao, B.; Shouery, M.; Shaw, M.; Rogak, L. J.; Wilson, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J.; Divgi, C. R.; Slovin, S.; Kelly, W. K.; Rathkopf, D.; Gignac, G. A.; Solit, D.; Schwartz, L.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Volumetric 3D CT analysis - an early predictor of response to therapy
    Meeting Abstract

    Schwartz, L. H.; Curran, S.; Trocola, R.; Randazzo, J.; Ilson, D.; Kelsen, D.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G ("acquired resistance") followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)
    Meeting Abstract

    Riely, G. J.; Kris, M. G.; Schwartz, L. H.; Akhurst, T.; Zhao, B.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Pegylated interferon alpha-2B (PEG-Intron) for metastatic renal cell cancer (mRCC): Results of a phase II clinical trial and biologic correlates of response
    Meeting Abstract

    Kondagunta, G. V.; Bacik, J.; Ishill, N.; Reuter, V.; Schwartz, L. H.; Korkola, J.; Deluca, J.; Sweeney, S.; Chaganti, R. S. K.; Motzer, R. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
    Journal Article

    O'Connor, O. A.; Heaney, M. L.; Schwartz, L.; Richardson, S.; Willim, R.; Macgregor-Cortelli, B.; Curly, T.; Moskowitz, C.; Portlock, C.; Horwitz, S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
    Journal Article

    Kelly, W. K.; O'Connor, O. A.; Krug, L. M.; Chiao, J. H.; Heaney, M.; Curley, T.; MacGregore-Cortelli, B.; Tong, W.; Secrist, J. P.; Schwartz, L.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer
    Journal Article

    Kelly, W. K.; Curley, T.; Slovin, S.; Heller, G.; McCaffrey, J.; Bajorin, D.; Ciolino, A.; Regan, K.; Schwartz, M.; Kantoff, P.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostrate cancer
    Journal Article

    Zelefsky, M. J.; Kelly, W. K.; Scher, H. I.; Lee, H.; Smart, T.; Metz, E.; Schwartz, L.; Fuks, Z.; Leibel, S. A.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Bicalutamide for advanced prostate cancer: The natural versus treated history of disease
    Journal Article

    Scher, H. I.; Liebertz, C.; Kelly, W. K.; Mazumdar, M.; Brett, C.; Schwartz, L.; Kolvenbag, G.; Shapiro, L.; Schwartz, M.
    Journal of Clinical Oncology (1997)

    Fulltext@MSK | Save